{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:19:30Z","timestamp":1781299170093,"version":"3.54.1"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Influenza infection could be associated with a long-term increase in the risk of Parkinson disease (PD). However, the benefit of influenza immunization as a preventive measure for PD remains unknown.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess whether immunization for influenza at midlife (between age 40 and 50 years) is associated with a decreased risk of PD.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study used electronic medical records from the UK\u2019s Clinical Practice Research Datalink Aurum. The study cohort comprised individuals vaccinated for influenza between 40 and 50 years of age (hereafter, with influenza immunization at midlife) from 1995 to 2017 and unvaccinated controls (hereafter, without influenza immunization at midlife) matched 1:1 on age, sex, socioeconomic status, and calendar month of the vaccination. All analyses were conducted between January and May 2025.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was incident PD. A modified intention-to-treat exposure definition with a 2-year lag period was applied to assess the risk of incident PD associated with influenza immunization at midlife vs no influenza immunization at midlife. Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% CIs of the study outcome. Inverse probability of censoring weighting was used to account for selection bias, and propensity score matching was used for confounding control. Secondary analyses assessed potential effect size modifiers. Sensitivity analyses explored the implications of different potential biases.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study cohort included 1 191 209 individuals (mean [SD] age, 44 [3] years; 673 920 females [56.6%]), of whom 612\u202f974 received influenza immunization at midlife and 578\u202f235 did not receive influenza immunization at midlife . Influenza immunization at midlife vs lack thereof was not associated with the risk of PD overall (crude incidence rates per 1000 person-years, 0.16 vs 0.10; matched HR, 0.96; 95% CI, 0.76-1.22). Results varied over time, with the lowest point estimate approximately 8 years after vaccination (HR, 0.75; 95% CI, 0.52-1.08), but none of the differences were statistically significant. Results also varied by seasonality, with a lower point estimate for those vaccinated during influenza season (matched HR, 0.62; 95% CI, 0.33-1.15) compared with those vaccinated outside of influenza season (matched HR, 1.07; 95% CI, 0.81-1.42). Stratification by age, sex, or vaccination prior to cohort entry did not modify the association. Sensitivity analyses supported the findings of the primary analysis.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cohort study found that influenza immunization at midlife was not associated with the risk of PD in the overall population. Potential benefits for PD risk occurring several years after vaccination or in specific patient subgroups require further investigation.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.47140","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:30:40Z","timestamp":1764952240000},"page":"e2547140","source":"Crossref","is-referenced-by-count":2,"title":["Influenza Immunization at Midlife and the Risk of Parkinson Disease"],"prefix":"10.1001","volume":"8","author":[{"given":"Antonios","family":"Douros","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacology and Toxicology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany"},{"name":"Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cui","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Lady Davis Institute, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dell\u2019Aniello","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Lady Davis Institute, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Suissa","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Centre for Clinical Epidemiology, Lady Davis Institute, Montr\u00e9al, Quebec, Canada"},{"name":"Department of Medicine, McGill University, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brassard","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Centre for Clinical Epidemiology, Lady Davis Institute, Montr\u00e9al, Quebec, Canada"},{"name":"Department of Medicine, McGill University, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"10423","key":"zoi251278r2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease.","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"issue":"10423","key":"zoi251278r3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease.","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"10423","key":"zoi251278r4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson\u2019s disease.","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"zoi251278r5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/JPD-212929","article-title":"The role of pathogens and anti-infective agents in Parkinson\u2019s disease, from etiology to therapeutic implications.","volume":"12","author":"Shen","year":"2022","journal-title":"J Parkinsons Dis"},{"issue":"33","key":"zoi251278r6","doi-asserted-by":"publisher","first-page":"14063","DOI":"10.1073\/pnas.0900096106","article-title":"Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration.","volume":"106","author":"Jang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"zoi251278r7","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1073\/pnas.1906466117","article-title":"Disruption of cellular proteostasis by H1N1 influenza A virus causes a-synuclein aggregation.","volume":"117","author":"Marreiros","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"zoi251278r8","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/mds.25077","article-title":"Association of Parkinson\u2019s disease with infections and occupational exposure to possible vectors.","volume":"27","author":"Harris","year":"2012","journal-title":"Mov Disord"},{"issue":"5","key":"zoi251278r9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3109\/00207454.2012.760560","article-title":"Infections as a risk factor for Parkinson\u2019s disease: a case-control study.","volume":"123","author":"Vlajinac","year":"2013","journal-title":"Int J Neurosci"},{"issue":"12","key":"zoi251278r10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jamaneurol.2021.3895","article-title":"Long-term risk of Parkinson disease following influenza and other infections.","volume":"78","author":"Cocoros","year":"2021","journal-title":"JAMA Neurol"},{"issue":"8","key":"zoi251278r11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer\u2019s disease.","volume":"390","author":"Jia","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi251278r12","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum.","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"key":"zoi251278r14","doi-asserted-by":"publisher","first-page":"vII14","DOI":"10.1007\/s00415-004-1705-4","article-title":"A prospective study of alcoholism and the risk of Parkinson\u2019s disease.","volume":"251","author":"Hern\u00e1n","year":"2004","journal-title":"J Neurol"},{"issue":"16","key":"zoi251278r15","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios.","volume":"32","author":"Austin","year":"2013","journal-title":"Stat Med"},{"issue":"3","key":"zoi251278r16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.0006-341X.2000.00779.x","article-title":"Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests.","volume":"56","author":"Robins","year":"2000","journal-title":"Biometrics"},{"issue":"12","key":"zoi251278r17","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting.","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi251278r19","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1001\/jama.1969.03160070046011","article-title":"Amantadine in the treatment of Parkinson\u2019s disease.","volume":"208","author":"Schwab","year":"1969","journal-title":"JAMA"},{"issue":"12","key":"zoi251278r20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1474-4422(21)00249-0","article-title":"Amantadine in the treatment of Parkinson\u2019s disease and other movement disorders.","volume":"20","author":"Rascol","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"zoi251278r21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3233\/JAD-201534","article-title":"Infectious disease burden and the risk of Alzheimer\u2019s disease: a population-based study.","volume":"81","author":"Douros","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"zoi251278r22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.15585\/mmwr.mm7406a2","article-title":"Interim estimates of 2024-2025 Seasonal influenza vaccine effectiveness\u2014four vaccine effectiveness networks, United States, October 2024-February 2025.","volume":"74","author":"Frutos","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi251278r1","unstructured":"Statistics. Parkinson\u2019s Foundation. Accessed March 27, 2025. https:\/\/www.parkinson.org\/understanding-parkinsons\/statistics"},{"key":"zoi251278r13","unstructured":"English indices of deprivation 2015. GOV.UK website. Accessed March 27, 2025. https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015"},{"key":"zoi251278r18","unstructured":"UK Health Security Agency. Timing of influenza seasons. GOV.UK website. Accessed March 27, 2025. https:\/\/www.gov.uk\/government\/publications\/respiratory-virus-circulation-england-and-wales\/timing-of-influenza-seasons"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2842395\/douros_2025_oi_251278_1767113732.36553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:00:33Z","timestamp":1767888033000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2842395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.47140","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}